ClinicalTrials.gov
public full text
Public Domain
NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Optimization and Application of CRISPR/Cas-based in planta Gene Targeting Technologies / Seda Yaşar ; Holger Puchta, Peter Nick#1052387
- Allogeneic CRISPR-Engineered CAR-T Cells Drive Potent Antitumor Activity in Solid Tumors#234305
- Machine-learning in optimization of CRISPR technology.#1068729
- CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma#463724
- CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and … — Vertex Pharmaceuticals Incorporated (US20250041349A1)#653949
Record · ID 651248
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive